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2 ABBREVIATIONS 
	
BMI  Body mass index 
CABG  Coronary artery bypass grafting 
CAD  Coronary artery disease 
CI  Cardiac index 
COPD  Chronic obstructive pulmonary disease 
CP  Constrictive pericarditis 
CPB   Cardiopulmonary bypass 
CT  Computed tomography 
dl   deciliter 
Fig.   Figure 
GFR  Glomerular filtration rate 
HR  Hazard ratio 
ICU   Intensive care unit 
K-M  Kaplan-Meier curve 
LV  Left ventricle 
m2  Square meter 
mg  Milligram 
MI  Myocardial infarction 
MRI  Magnetic resonance imaging 
min  Minute 
NSAID Nonsteroidal anti-inflammatory drugs 
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NYHA  New York Heart Association (Classification) 
OR  Odds ratio 
PAPPi  Pulmonary artery pulse pressure index 
PCP   Post-surgical constrictive pericarditis 
®  Registered trade mark 
ROC   Receiver operating characteristic 
SLE  Systemic Lupus Erythematosus 
Tab.   Table 
TEE   Transesophageal echocardiography 
TR  Tricuspid valve regurgitation 
TV  Tricuspid valve 
TVR  Tricuspid valve repair 
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3.1 REVIEW 
 
Constrictive pericarditis (CP) is an uncommon disease with multiple causes 
and discrepant clinical outcome. Till date, there is a scarcity of 
publications, clearly defining the risk factors of poor outcomes after 
surgery for CP. Therefore, we retrospectively analysed the results of the 
surgical treatment for CP at our institution to define the risk factors of 
poor outcomes.  
A total of 97 patients (65 male, 67%) undergoing surgery for CP at our 
institution from 1995 to 2012 were included in this study. CP was 
diagnosed either preoperatively by cardiac catheterization or at surgery. 
The mean age was 60±12.5 years and the primary etiology was idiopathic 
in more than halt the cases, followed by prior cardiac surgery, post-
irradiation, and miscellaneous. Preoperative and intraoperative risk factors 
for 30-day and late mortality were analyzed using stepwise multivariate 
logistic and Cox regression analysis respectively. Long-term survival was 
determined by the Kaplan-Meier curve. Mean follow-up was 2.9±3.8 years 
(range: 0.1-14 years). 
All patients received either radical (53 patients, 55.2%) or partial (44 
patients, 44.8%) pericardiectomy. Concomitant procedures were 
performed in 38 (39,2%) patients. Overall 30-day, 1-year and 5-year 
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survival were 66.8 %, 58.1% and 52.6% respectively, without significant 
difference according to the underlying etiology. Univariate analysis 
showed that preoperative renal dysfunction, liver failure, respiratory 
insufficiency, emergency surgery and longer operating times were 
associated with significantly higher 30-day mortality. Multivariate analysis 
revealed patients with concomitant coronary artery disease to be at higher 
risk of poor immediate survival, whereas a higher glomerular filtration 
rate GFR (ml/min/1,73m2) was protective for early mortality. Long-term 
mortality was independently predicted by the presence of a coronary 
artery disease, a COPD (chronic obstructive pulmonary disease) and 
higher absolute creatinine value.  
To conclude, surgery for constrictive pericarditis is associated with a 
relatively poor prognosis. Reduced left ventricular ejection fraction and 
right ventricular dilatation were independent predictors for early mortality, 
while coronary artery disease, chronic obstructive pulmonary disease, and 
renal insufficiency were risk factors for late mortality. Thus, indication for 
surgery needs to be determined on an individual basis and should be 
justified by an otherwise worse natural prognosis. 
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4 INTRODUCTION 
 
4.1 CHRONIC CONSTRICTIVE PERICARDITIS 
 
Many diseases of the cardiovascular system attract the attention of the 
clinicians and care for excitement. The unique thing about the diesaes of 
the pericardium is that it cares for controversies 1, expressive debates 
among the physicians and the surgeons 2, and represents a steping stone 
for the diagnosis as well as for the treatment 3. Unlike other diseases, 
especially the constrictive pericarditis represents a rare condition with 
many different signs and symptoms changing through the natural 
progress of the disease. With that on one side it still cares for 
troublesamong the cardiologists in the decision making among the 
restrictive and constrictive pattern of myocardial disease, and on the other 
side among the surgeons for the timing and justification of the indication 
for surgery.  
The pericardium is a very important structure in the proper functioning of 
the heart as a whole. It represents a barrier for the heart from the 
surrounding in the mediastinum. There are many states that are in a 
dynamic change in the chest and in the mediastinum4 that could have a 
repercusion on the heart’s work. Thus, isolating the heart from the 
surrounding, the pericardium itself is exposed to this processes as well, 
and they are affecting it. In physiological environment, the constant 
friction from the inside during the heart cycle, is eased through the small 
amount of fluid content inbetween the two layers of the pericardium.  
As a fibroserous membrane, the pericardium is composed of two layers: a 
visceral and parietal pericardium 4. The former is also known as 
epicardium, a serous elastic membrane surrounding the four heart 
chambers. It is considered that the epicardium is responsible for secretion 
of the small amount of fluid (in adult about 20-60 mL, average 15-35 mL) 
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56 that lubricates the surfaces and enables smooth friction. The flat 
surface of the epicardium is covered by one layer of flat epithelial cells, so 
called mesothelials or mesothelium. The parietal pericardium, adding to 
the seroelastic layer contains also a fibrous layer, comprised of collagen 
and elastin fiber, giving the elasticity and certain strength. The 
pericardium as a whole brings to bear many important functions as is 
limits the intrathoracic cardiac motion, fights acute dilatation, balances 
the right and left ventricular (RV and LV, respectively) output through 
diastolic and systolic interactions 4 ect.  
Being hit by infections, surgery, radiation, autoimmune and rheumatic 
disease, the pericardium often becomes thickend, fibrotic, scarred or 
calcified. This state is usualy reached after a longer period of time, an 
acute and chronic inflamation, all resulting in the constrictive nature of the 
pericardium.  
Constrictive pericarditis (CP) is an uncommon disease with multiple causes 
and discrepant clinical outcomes. It is characterized by a long-lasting 
asymptomatic phase followed by a state of chronic right heart 
decompensation and low systemic output. Pericardiectomie is the only 
therapy to relieve right ventricular constraint and improve symptoms. 
Despite all the recent advances in cardiac surgery, pericardiectomy is still 
associated with a high morbidity and mortality in the peri- and 
postoperative period. However, it is still not clear which preoperative 
factors might predict a poor outcome after surgical treatment approach. 
In the last ten years, few studies worldwide presented consistent results 
concerning surgical mortality7–11, ranging from 1.2% in South Korea 8, 7% 
in another German center9, and 8.6% in Turkey 11. Two studies published 
in 2013 presented nationwide results for pericardiectomy: one from 
Tokuda et al., Japan12 and the other from Gopaldas et al.,13 USA. The 
former one presented an operative and a composite mortality or major 
morbidity rate of 10.0% and 15.0% respectively. 
This study follows the experience in a single center in Europe during the 
last two decades; to our best knowledge it is the largest study to deal with 
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CP on the European continent so far. Nonetheless, it includes not only 
patients with symptoms expressing the constrictive pathology, but also 
combined coronary artery disease and valvular pathologies. 
So far, the only curative approach in the treatment of the constrictive 
pericarditis is the surgical pericardiectomy. The indication, the forms, the 
risk, and the ourcome after pericardiectomy will be thoroughly discussed 
in this manuscript. 
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4.2 HISTORY 
 
To reach the heart, one must open the pericadium. This silent structure 
has attracted the attention of the physicians from ancient times. The first 
description of a pericardial effusion was given by Galen around the year 
160 AD. He made his observations on a monkey and in cock, assuming 
that this condition could also occur and cause improper functioning of a 
human’s heart as well. To his name is contributed the first record of a 
pericardial resection, made on a young man suffering from post-traumatic 
septic anterior mediastinis14.  
Earliest manuscripts describing diseases of the pericardium are found in 
medieval Spain where Avenzoar (1113-1162) described a serofibrous 
pericarditis. Giovanni Lancisi (1654-1720) described the clinical 
significance of the pericardial adhesions 4. The English physician Richard 
Lower (1631-1691) first clinically described the constrictive pericarditis. 
He wrote about dyspnea and an intermittent pulse in a patient with CP 15. 
Gioavanni Battista Morgagni, an Italian anatomist (1682-1771), was 
probably the first one to address the problem of an inadequate blood 
supply to the body as a consequence that the heart did not receive 
enough blood16. Dominic Corrigan (1802-1880) is attributed with the 
original description of the pericardial knock in 1842 17. He was followed by 
Kussmaul, who described the paradoxical arterial pulse in 1873.  
 
Around this time the eponym Pick’s disease came into use. Friedel J. Pick 
(1867-1926) is credited for the remarkable step putting it all together as a 
syndrome in 1896 14. It was connected to a constrictive pericarditis with 
ascites and hepatomegaly caused by a pseudocirrhosis or later known as 
“cirrhose cardiaque”.  
In many sights futile surgical procedure was performed by Ludolph Brauer 
(1865-1951), described in 1902. He resected ribs and costal cartilages for 
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surgical management of CP. In the meantime, surgical expertise was 
improved by Edmond Weill (1858-1924) in 1895; and later in 1898, 
Edmond Delorme (1847-1929) introduced the idea of cardiac 
decortication.  
 
At the brake of the 20th century and in its early decades, their work was 
continued by Ludwig Rehn (1849-1930) and Ferdinand Sauerbruch (1875-
1950), both of whom reported on performing pericardiectomies in 191316. 
Franz Volhard (1872-1950), the excellent German clinician and an intent 
clinical researcher together with his surgical colleague Victor Schmieden 
(1874-1945), made a huge contribution to the understanding of the 
pathophysiology of the disease, and to the importance of the course of the 
operation. In their classic paper of 1923 they describe the importance of 
the course of the pericardiectomy, by first freeing the left ventricle and 
then the right one18. Comprehensive description of the etiology, diagnosis 
and treatment for constrictive pericarditis was made by Paul Dudley White 
(1886-1973) in his historic paper from 1935, following his speech held the 
same year at the Royal Society of Medicine in London14.  
 
After the Second World War and advances in technology, especially heart 
catheterisation and radiologic methods in medicine, Bloomfield described 
the elevated right atrial and ventricular pressure; Hansen dealt with the 
dip-and-plateu sign and Hancock contributed the term effusive constrictive 
pericarditis19. Last but not least, a remarkable contribution to defining the 
disease and bring its management to its present state was brought by the 
experimental work of Emile Holman (1890-1977). His work published in 
1949 left behind indisputable facts about the importance of the complete 
pericardiectomy16. 
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4.3 DEFINITION 
 
4.3.1 Acute pericarditis 
 
Acute inflammation of the pericardium, isolated or as a part of a systemic 
inflammation of any cause, is called acute pericarditis. It is quite common 
state including at least in 0.1% of hospitalized patients and approximately 
5% of patients admitted to the emergency department with chest pain not 
related to cardiovascular cause20. Acute pericarditis can be manifested as 
dry, fibrinous or effusive, independent from the underlying etiology. 
Usually fever, malaise, and myalgia are symptoms preceding its 
manifestation21. There is no definitive diagnostic algorithm for acute 
pericarditis, but there are some well established criteria gained from 
previous observational studies that are in use for the diagnosis of the 
disease20,21: 1) retrosternal or left precordial chest pain, which radiates to 
the trapezius ridge, can be pleuritic or can simulate ischemia, and 
characteristically varies with posture; 2) pericardial friction rub, which can 
appear on auscultation as mono-, bi- or triphasic, and can be transient; 3) 
specific electrocardiographic changes are often present; 4) pleural 
effusion; 5) heart rate faster than normal but regular, if no underlying 
rhythm problems are present. 
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4.3.2 Recurrent pericarditis 
 
Two conditions exist within the term recurrent pericarditis: 
 
1) intermittent type of recurrent inflammation, with symptom-free 
intervals without treatment, and 
2) incessant type of recurrent inflammation, where discontinuation of 
anti-inflammatory treatment grants a relapse.  
 
In any of these states, significant pericardial effusion, pericardial 
tamponade or constriction is rare 21. Currently there is no definitive 
optimal treatment for the recurrent (relapsing) pericarditis. Due to a small 
patient population in published studies on pericarditis including recurrent 
pericarditis, the exact frequency of recurrent pericarditis is not 
established. It varies from 8% to 80%, with an average of 24% of the 
patients showing evidence of acute pericarditis20. 
 
Recurrent pericarditis is linked to an immune-pathological process 
characterized by: 1) the latent period lasts for months, 2) anti-heart 
antibodies are present, 3) responds quickly to steroid treatment and other 
immunosuppressive medication, and coexists with other autoimmune 
conditions (SLE, serum sickness, polyserositis, postpericardiectomy/ 
postmyocardial infarction syndrome, celiac disease, dermatitis 
herpetiformis, frequent arthralgias, eosinophilia, allergic drug reactions 
and history of allergy)20. A potential genetic disorder has also been 
reported, with autosomal dominant and sex-linked inheritance 22 23. Other 
causes of relapsing pericarditis include viral infections, and also idiopathic. 
Tuberculous, purulent, and/or neoplastic pericarditis are not recognized 
causes of recurrent pericarditis20.   
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4.3.3 Pericardial effusion, pericardial tamponade, effusive-
constrictive pericarditis 
 
The normal healthy human pericardium is generally considered to contain 
20-25 ml of physiologic fluid 24. Presence of a larger than physiological 
amount of fluid in the pericardial sack is a condition known as pericardial 
effusion. Depending on the underlying etiology that caused the effusion, 
the fluid has different characteristics: transudate (or hydropericardium), 
exudate (inflammatory effusion rich in proteins), pyopericardium (purulent 
effusion), or haemopericardium (blood effusion)21. Effusion developing 
over a longer time can remain unrecognized and is remarkably 
asymptomatic, while rapid development of an even smaller pericardial 
effusion can cause a pericardial tamponade and severe clinical symptoms. 
Larger effusions are associated with neoplastic, tuberculous, uremic, 
myxedema, and parasitic pericarditis (extremely rare though, associated 
with Entamoeba hystolytica, and Trypanosoma cruzi) 2526. Scarring as a 
result of postsurgical, posttraumatic, and purulent pericarditis usually 
causes so-called loculated effusions. Massive chronical effusions are 
rare21.  
Pericardial effusions can occur without causing cardiac tamponade20. 
Cardiac tamponade is the decompensated stage of cardiac compression as 
a result of effusion accumulation and consecutively raised intrapericardial 
pressure21. According to the direct underlying cause, the tamponade can 
be also divided into: “surgical” tamponade, usually caused by 
haemorrhage, where the intrapericardial pressure rises rapidly, minutes to 
hours; and “medical” where a low-intensity inflammatory process 
develops and takes days to weeks before cardiac compression is evident, 
i.e. Dressler syndrome 21. In this regard, an acute tamponade can occur 
after accumulation of as little as 150-200 ml of fluid within few minutes to 
hours, whereas a massive chronic effusion that will cause tamponade can 
become as large as 500-2000 ml, accumulating over days and weeks 
distending the pericardium 27. Nearly a third of the patients who have 
large pericardial effusions develop tamponade unexpectedly and abruptly 
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28. Some experts recommend drainage for large pericardial effusions (>20 
mm seen on echocardiography), if persistent for more than a month and if 
the right side of the heart is collapsing. Smaller pericardial effusions that 
tend to regress but also reoccur, demand regular follow up with a clinical 
examination and echocardiography20.  
 
Effusive-constrictive pericarditis represents an uncommon pericardial 
syndrome and can be easily missed in patients presenting with clinical 
signs of tamponade. The causes are different: more common after 
irradiation, and somewhat less common after surgery29. In case it appears 
to be a “transient” or medically treatable constrictive pericarditis, it is 
probably a late stage of effusive-constrictive pericarditis. A very useful 
diagnostic hint is measuring the hemodynamics before and after 
pericardiocentesis. In the case of effusive-constrictive pericarditis the 
hemodynamics doesn’t normalize after effusion drainag30.  
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4.3.4  Chronic pericarditis 
 
If the symptoms of effusive, adhesive, and constrictive pericarditis last 
longer than 3 months, it is considered chronic31. Chest pain, palpitations, 
fatigue and other unspecific findings may be present. They are dependent 
on the extent of the inflammation and the degree of cardiac compression. 
Diagnosis is set upon a similar algorithm as for acute pericarditis (Figure 
1)21. If a curable cause can be detected, such as tuberculosis, and other 
chronic infectious diseases, autoimmune diseases, chronic systemic 
inflammatory disease, it should be primarily treated. If the symptoms 
persist and don’t alleviate on medical therapy, pericardiocentesis is 
indicated. For longer persisting symptoms, or frequent and symptomatic 
recurrences that last longer, a endoscopic or open pericardiectomy should 
be considered 21.  
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Figure 1. Diagnosis of constrictive pericarditis	
(©Springer Science+Business Media, LLC 2012, Heart Fail Rev (2013) 18:375–387, 
Surgery for pericardial disease, Page 379, Yang Hyun Cho, Hartzell V. Schaff. 
With kind permission of Springer Science+Business Media). 
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4.3.5 Chronic constrictive pericarditis 
 
Chronic constrictive pericarditis is a consequence of chronic inflammation 
of the pericardium that leads to impaired cardiac filling and reduced 
ventricular function21. It is still an elusive diagnosis, since it cannot be 
simply characterized by a few minor or major criteria 32. The diagnosis 
may still remain ambiguous, even after clinical examination and testing 
with 2D and Doppler echocardiography, as well as with cardiac CT (Figure 
2) and cardiac MRI20. Historically, the classic form of calcified constrictive 
pericarditis was caused by tuberculous infection. Recently it has shifted to 
predominantly idiopathic etiology, which goes back to viral infection, or 
after surgery or non-surgery related hemorrhagic effusions, trauma, 
irradiation or other non-tuberculous infections32. If diagnosed early in the 
progression of the disease, it is potentially curable, and the only curative 
treatment is pericardiectomy20.  
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Figure 2. 3D reconstruction of a multi-slice computed tomography (CT) 
image of a calcified constrictive pericarditis, a typical “eggshell” formation 
(Patient from our series) 
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4.3.6 Clinical presentation  
 
Constrictive pericarditis appears with signs and symptoms consistent for 
disabling chronic right-side heart failure. In this regard, the signs and 
symptoms can be observed either as symptoms related to volume 
overload or reduced cardiac output symptoms 33.  
 
Early-stage signs are usually lower-limb edema, and also symptoms from 
mild hepatic congestion like tender right subcostal space. In the course of 
the disease, the symptoms of hepatic congestion become enhanced and 
include development of ascites, anasarca and jaundice 34. Anorexia and 
nausea are common accompanying symptoms, as a result of bowel 
congestion after the prolonged hepatic congestion 35. As the disease 
advances, the symptoms of reduced cardiac output become more evident: 
dyspnea and orthopnea, weakness and exercise intolerance. Later on, 
approaching to end stage disease muscle wasting, severe fatigue and 
cachexia may be observed.  
 
On physical examination, usually first signs to be noticed are jugular vein 
distention with Kussmaul’s sign 35 (paradoxical rise in the jugular venous 
pressure with inspiration), pulsatile liver, “silent precordium” with a 
pericardial knock on auscultation, peripheral edema (may be absent in 
young patients 34), and eventually distended abdomen with ascites; also 
advanced signs of liver disease as jaundice can be present. Another sign 
described by Kussmaul is the irregular and disappearing pulse with every 
inspiration, so called “pulsus paradoxus” 34. Paradoxical pulse is 
considered the decrease in blood pressure exceeding 10mmHg during 
inspiration. At the same time it can be observed also in patients with 
cardiac tamponade, pericardial effusion, restricted cardiomyopathy, acute 
myocardial infarction, severe pulmonary embolism, bronchial asthma, and 
tension pneumothorax. It should be kept in mind that finding a 
17	
	
paradoxical pulse that exceeds 10mmHg is commonly accompanied by 
excessive pericardial fluid 27. 
 
Pleural effusions are also present. ECG reveals normal QRS axis with low 
voltage, and non-specific generalized T wave flattening or inversion. A 
notched P wave in terms of P-mitrale is present in almost half of the 
patients, whereas a P-wave coming from left atrial enlargement is present 
in almost one third of the patients 36.  
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4.3.7 Diagnostic approach 
 
1) Physical examination: see clinical presentation. 
2) Laboratory investigation: No specific inflammatory markers are 
characteristic for constrictive pericarditis. ProBNP is usually not 
elevated despite volume overload. Its level rises after 
pericardiectomy, as the atria can again distend. Characteristic 
finding for chronic constrictive pericarditis and retrograde congestion 
is severe hypoproteinemia, caused by protein-losing enteropathy 
and ascites. The syndrome develops due to chronically elevated 
inferior or superior vena caval pressure 37.  
3) Non-invasive visualization methods: 
- Chest x-ray: on chest radiography of patients with constrictive 
pericarditis after tuberculosis, pericardial calcifications may be 
evident (Figure 3a, and 3b). 
Figure 3a: Chest x-ray in anteroposterior view of a patient with 
calcified constrictive pericarditis (Patient from our series). 	
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Figure 3b: Chest x-ray of the same patient in lateral view. 
 
- Other reported that calcifications are usually present after a 
longer duration of the disease, irrespective of the etiology20. They 
are not a valuable diagnostic marker. An enlarged cardiac 
silhouette may be present in case of effusion32. If the disease is 
in a rather advanced stage pleural effusion can be evident. 
Pulmonary vascular congestion is present if the left-sided filling 
pressures are elevated30. An radiopaque shadow over the right 
heart and atrioventricular grove should be distinguishable from a 
calcified left ventricular aneurysm38, both conditions being very 
rare. 
- Echocardiography: it is usually the initial and the most valuable 
non-invasive diagnostic tool for setting the diagnosis, confirming 
it, and distinguishing it from restrictive cardiomyopathy. The 
whole examination can be grouped in three aspects. First, 
Doppler hemodynamics with color Doppler; second, LV 
mechanics, with accompanying septal involvement; and third, 
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auxiliary cardiac anatomy findings39. Doppler measurements 
reveal excessive respiratory variations in both mitral and 
tricuspid inflow velocities. These 180-degree out of phase 
disparities in the inflow velocities can somewhat overlap with 
findings in tamponade, but are comparably specific and sensitive 
for diagnosing constriction30. The 25% or greater increase in 
mitral E velocity during expiration accompanied by reversal of 
diastolic flow into the hepatic veins is a characteristic of 
constriction30. However, some 20% of patients do not show this 
typical pattern, probably due to increased left atrial pressure. In 
such cases, a preload reduction maneuver placing the patient in 
an upright seated position or administration of diuretics may 
unmask or boost the typical respiratory variation40. Left 
ventricular mechanics are characterized by changes in the radial 
motion of the posterior LV wall seen as flattening during mid-
diastole in M-mode, then by longitudinal LV motions (mitral 
annular velocity), circumferential and torsion mechanic (reduced 
net LV twist, distinguishing mark from the restrictive 
cardiomyopathy), and the most characteristic sign – an early 
diastolic left shifted interventricular septal bounce with reciprocal 
right-side rebound in expiration39. Auxiliary findings include 
pericardial thickness (transoesophageal echocardiography is 
superior to transthoracic, yielding comparable results with 
cardiac CT30), premature opening of the pulmonary valve due to 
right ventricular hypertension, and downward aortic root motion 
in early diastole39.  
- Cardiac magnetic resonance imaging and computed tomography: 
both techniques show the whole pericardium to the finest detail, 
and are absolute requirement in defining the surgical strategy. 
Cardiac MRI visualizes thickened pericardium from 3-4 mm, 
including the pericardial fluid 32. In this regard, the CT is more 
sensitive, it visualizes the pericardium from 2 mm, and also 
shows the slightest calcifications. The, MRI on the other hand, is 
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superior in depicting an inflammation, acute or chronic, using 
gadolinium in late enhancement. An important advantage of MRI 
over CT is the absence of radiation, as well as no need for iodine 
contrast medium. Other important information is the status of 
the myocardium after chronic constriction. The myocardium may 
develop fibrosis for a number of reasons during constriction: 
direct subpericardial penetration of the inflammatory process, 
compromised coronary artery flow either due to compression of a 
coronary artery or throttling of the arteries by scar tissue, or 
subendocardial rigidity and limited irrigation therefore, and 
concomitant myocardial process41. Important to mention is also 
the myocardial atrophy after chronic constriction and lack of free 
movement and distension of the myocardium. MRI can detect 
myocardial atrophy with high sensitivity and specificity. In case 
of present myocardial atrophy, pericardiectomy is 
contraindicated21. 
4) Invasive hemodynamic measurement: Cardiac catheterization and 
coronary artery angiography is essential to establish and confirm the 
diagnosis of constrictive pericarditis. In general, looking solely at the 
hemodynamic parameters and the characteristic equalization of the 
intracardiac pressures, the cardiac catheterization cannot distinguish 
between constriction and restriction. However, there are novel 
criteria from the catheterization lab that makes the difference clear3. 
In both conditions we see increased atrial pressure, equalization of 
end-diastolic pressure in all four chambers up to a difference of less 
than 5mmHg, and the characteristic “dip-plateau” phenomenon, also 
known as “square root sign”20. The “square root sign” (Figure 4) 
appears as a result of an rapid early diastole filling with a sharp y-
wave, followed by abrupt stop in the ventricular filling in late 
diastole, due to stiffened pericardium or restrictive myocardial 
pattern20. 
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Figure 4. Typical “dip-and-plateau” sign seen on pressure tracings cardiac 
catheterization 
 
 
  
 
 
 
 
 
 
 
*taken from Younger JF, A classical diagnosis with a  new ‘spin’, Ulster Med J (2008) 
The increased ventricular interdependence resulting from dynamic 
respiratory changes is characteristic for constriction and 
distinguishes the two conditions42. Also connected to this, the right-
to-left ventricular systolic area ratio during inspiration and 
expiration, which again incorporates the concept of ventricular 
interdependence is specific of a constrictive hemodynamics3. For 
patients older than 35 years, coronary angiography is mandatory21. 
In our study this age limit was set at 45 years.  
* For detailed description on the diagnostic approach, please see Attachment 1: 
Diagnostic approach in constrictive pericarditis, from the Guidelines on the Diagnosis and 
Management of Pericardial Diseases - Executive Summary, from The Task Force on the 
Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology 
(Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al. Guidelines on 
the diagnosis and management of pericardial diseases executive summary; The Task 
force on the diagnosis and management of pericardial diseases of the European society 
of cardiology. Eur Hear. J 2004 Apr;25(7):587–610.) 
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4.3.8 Treatment options 
 
While for acute and recurrent pericarditis few anti-inflammatory agents 
show reliable effectiveness, and also in isolated cases of transient 
constriction, the only treatment option for chronic constrictive pericarditis 
is surgical excision of the pericardium (Figure 5).  
 
Figure 5. Treatment algorithm for transient and constrictive pericarditis 
 
(©Springer Science+Business Media, LLC 2012, Heart Fail Rev (2013) 18:375–387, 
Surgery for pericardial disease, Page 379, Yang Hyun Cho, Hartzell V. Schaff. 
With kind permission of Springer Science+Business Media) 
 
First a short review of the current recommended medical therapy: NSAID 
are first line therapy 43, and colchicine has shown best in preventing 
recurrence 44. Corticosteroids are still largely in use, but there are still 
certain controversies connected to their use 43.  
  
Treatment	
Transient	constric4ve	pericardi4s	 Chronic	constric4ve	pericardi4s	
Consider	medical	therapy	alone	
	NSAIDs	
	Cor4costeroids	
	Treatment	of	heart	failure	
			ACE	inhibitors	and	diure4cs	
	Chemotherapy	
If	medical	treatment	failure	 Consider	complete	surgical	pericardiectomy		
Associated	with	high	opera4ve	mortality	(>6%)	
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Invasive therapeutical strategies include: 
1. Pericardiocentesis and placement of a drain.  
2. Mediastinoscopy including biopsy to receive more diagnostic 
information. 
3. Mediastinal exploration to gain histological material. 
4. Pericardial windowing. It can be performed through a subxyphoidal 
approach, or transpleural. 
 
The indication for mediastinal exploration is usually infective pericarditis or 
immediate postoperative effusion or tamponade, because the incision is 
already there. The advantage of pericardial windowing is to create a 
communication of the pericardium to the pleural space, where eventual 
later effusion can be continuously drained.  
 
4.3.9 Pericardiectomy  
 
The indication for pericardiectomy is constrictive pericarditis itself 37. If the 
physiological effects are minimal or the symptoms are not that 
pronounced, the surgery can be delayed for a certain period 37.  
 
Pericardiectomy can be performed through many approaches: medial 
sternotomy, left thoracotomy, and bilateral thoracotomy 45. Depending on 
the planned extent of the surgery, the approach will be chosen 
adequately. Typically, there are two types of pericardiecotmy in regard to 
extent of removal of pericardial tissue: partial (or anterior), and complete 
(or radical, described in three following steps, on Figure 6, Figure 7, and 
Figure 8). 
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Figure 6. Steps in radical pericardiectomy. The upper left panel 
demonstrates an initial dissection of the anterior pericardium which is 
limited by the right and left phrenic nerves. 
 
(©Springer Science+Business Media, LLC 2012, Heart Fail Rev (2013) 18:375–387, 
Surgery for pericardial disease, Page 381, Yang Hyun Cho, Hartzell V. Schaff. 
With kind permission of Springer Science+Business Media). 
 
 
Partial pericardiectomy is removal of the anterior pericardium from the 
right to the left phrenic nerve. Complete or radical pericardiectomy in 
contrast includes removal of the whole pericardium except for the 
pericardium lying posterior to the left atrium in the oblique sinus. That 
includes the diaphragmal and the part behind the left phrenic nerve 45. If 
the indication for pericardiectomy is recurrent inflammatory pericarditis, 
removal of the pericardium overlying the atria is advised (so-called 
epicardectomy 46). Otherwise, for constriction removal of the majority of 
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pericardium surrounding the ventricles is sufficient 45. There is still an 
ongoing debate if partial or radical pericardiectomy is necessary. 
Supporters of both views have published arguments for their strategy 47–
49.  
Figure 7. Steps in radical pericardiectomy. After careful identification of 
the left phrenic nerve, it is often possible to remove pericardium posterior 
to the left phrenic nerve. This is most easily done after the diaphragmatic 
portion of the heart is freed from constriction. 
 
(©Springer Science+Business Media, LLC 2012, Heart Fail Rev (2013) 18:375–387, 
Surgery for pericardial disease, Page 382, Yang Hyun Cho, Hartzell V. Schaff. 
With kind permission of Springer Science+Business Media) 
 
Also different strategies are supported concerning the use of 
cardiopulmonary bypass. On one hand, cardial decompression allows more 
manipulation and facilitates dissection; on the other hand CPB and 
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heparinization causes additional coagulopathy and tendency for bleeding 
in an already relative worsened coagulation status and a large surgical 
dissection plane 45,48. However a patient with volume overload from 
chronic constriction and impaired renal function can end up in an acute 
distention of the ventricles, especially of the right after removing the 
constriction. In such cases use of cardiopulmonary bypass is highly 
advised 45. 
 
Figure 8. Steps in radical pericardiectomy. With cephalad retraction of 
the heart, the diaphragmatic portion of the pericardium can be removed 
from the muscular and membranous regions of the diaphragm. 
 
(©Springer Science+Business Media, LLC 2012, Heart Fail Rev (2013) 18:375–387, 
Surgery for pericardial disease, Page 383, Yang Hyun Cho, Hartzell V. Schaff. 
With kind permission of Springer Science+Business Media) 
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Tricuspid valve regurgitation in constrictive pericarditis is not rare. Many 
reported mild to severe regurgitation preoperatively. In our experienceas 
well as in the literature the expansion of the ventricles after removal of 
the constriction leads to worsening of the present minimal to mild TR, and 
on long term the survival is affected 50.  
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5 AIM OF THE STUDY 
 
The primary end point of the study was to identify independent predictors 
that contribute to the operative outcome. This should be used, along with 
the conclusions from other studies, as a tool in the decision-making 
process for the most appropriate treatment for setting an indication for 
operation, and the timing of the procedure. 
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6 MATERIAL AND METHODS 
 
This is a retrospective cohort study. We used our prospectively managed 
cardiac surgery database to conduct a retrospective analysis of all patients 
who received operative pericardiectomy at our center. From October 1995 
to May 2012, a total of 97 consecutive patients with chronic CP underwent 
operative pericardiectomy in our institution. All patients’ data 
(demographic, laboratory tests, physical examination on admission, 
coronary catheterization with measurements of the left and right-heart 
sided pressures and volumes, right heart catheterization using the Swan-
Ganz® catheter, computed tomography of the chest and the heart, cMRI, 
echocardiography, intraoperative data and register from the heart-lung-
machine, ICU treatment protocol) were collected prospectively and stored 
in an institutional electronic data base. Through the whole period the 
patients were regularly followed either by a telephone interview or a 
postal questionnaire (see attachment 2.). All available data was 
retrospectively analyzed.  
 
6.1 DATA COLLECTION 
 
Microsoft® Excel® 2007 was used the as a program for primary database 
and back up and afterwards the data was transferred, defined and 
statistically processed using SPSS® 20 (IBM®) (both program versions for 
Windows®). The ethical board of the University of Leipzig approved the 
chart review, the queries of the electronic database, all analyses needed 
for the study as well as the extended follow-up questionnaire, which was 
sent per snail mail to the hospital survivors.  
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6.2 DIAGNOSIS OF CONSTRICTIVE PERICARDITIS 
 
The standardized preoperative work-up for every patient includes clinical 
examination, blood laboratory data, electrocardiogram, transthoracic 
echocardiogram, coronary angiography and chest X-ray. According to the 
clinical symptoms, an additional cardiac catheterization for hemodynamic 
measurements of all four chambers was performed. When indicated, a 
computed tomography scan of the chest was additionally obtained for 
visualization of the extent of pericardial thickening and calcifications or to 
see the proximity of the heart or coronary artery bypass grafts to the 
sternum. Intraoperatively, all patients were monitored by 
transoesophageal echocardiography and Swan–Ganz right-heart 
catheterization. 
 
 
6.3 OPERATIVE PROCEDURES 
 
All surgeries were performed at the Heart Center Leipzig, a tertiary clinical 
center, part of the University of Leipzig specializing in cardiac pathology. 
Every patient consented to the operation at least 24h prior to the surgery. 
Every patient was initiated into anesthesia following a standardized 
protocol. The same applies for the intraoperative management, monitoring 
and transfer of the patient to the intensive care unit (ICU). The patients 
evaluated preoperatively that fulfilled the house criteria for a “fast track 
surgery” were transferred to the special post-anesthesia recovery and 
care unit51. 
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6.4 OPERATIVE TECHNIQUE 
 
Each operation was performed in a standard sternotomy using an 
oscillating saw in redo cases. Compared with redo cases, we started with 
the approach to the pericardium at the right inferior aspect of the heart 
until severe calcifications were evident (mostly at the right atrium or the 
diaphragm). Then the free right ventricular wall and the aorta were 
mobilized until cannulation for CPB was possible. However, preparation 
was continued as long as possible without heparinization and CPB use. 
Firstly, the right pericardium was prepared from the right atrium until the 
phrenic nerve. In some cases, the right chest cavity was opened to 
facilitate preparation and to better identify the phrenic nerve. Pericardium 
was than resected at the right aspect. This also allowed better 
mobilization of the heart and preparation of the left ventricle. For this, 
Favaloro hooks or other sharp hooks allowed preparation to the apex 
without severe cardiac manipulation. Based on individual findings, either a 
left pericardiotomy to the phrenic nerve was performed without CPB or 
CPB was connected and the heart was unloaded to facilitate preparation 
and secure haemodynamic stability. Especially in CP patients with 
enlarged RVs, CPB was used liberally. Cautery was also used liberally to 
minimize bleeding (external defi pads necessary!). In case of total 
pericardiectomy, the heart was arrested and completely tilted to resect 
the posterior pericardium. 
Intracardial calcifications were common at the crux cordis and the free 
right ventricular wall. In these cases, CPB and an unloaded heart 
facilitated preparation and haemostasis and helped to avoid coronary 
injury. An off-pump blower was helpful in severe intracardiac 
calcifications. 
Concomitant cardiac procedures were then added with or without 
cardioplegic arrest based on an individual basis. Autologous fibrin glue 
was used in most cases to minimize parenchymal bleeding. 
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6.5 POSTOPERATIVE COURSE 
 
After the operation, the patients were transferred either to the 
interdisciplinary intensive care unit (ICU) or to the recovery room 
(“Aufwachraum”). The ICU was predominantly used for patients with a 
need for prolonged intensive care, whereas the recovery room was used in 
cases of “fast track” patients. All patients were monitored equally 
regardless of the unit transferred to, with central arterial line, central 
venous catheter, pulmonary catheter, hourly urine output reads, serial 
echocardiographic examinations, daily (or if necessary and by indication 
more than once a day) laboratory tests and coagulation status. The 
transition to the ward was made through the intermediate care unit A 
(ICA), where the patients were also continuously monitored, but without 
the use of pulmonary catheter.  
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6.6 INCLUSION CRITERIA 
	
Only patients with constrictive pericarditis confirmed at surgery or at 
preoperative cardiac catheterization were included in the study. The key 
characteristic used for inclusion was equilibration of the diastolic pressure 
in the four heart chambers. Additional features such as physical 
examination, echocardiography, CT scan, MRI, and right heart 
catheterization were taken into consideration for the definitive diagnosis. 
 
6.7 EXCLUSION CRITERIA 
	
Patients with recurrent constrictive pericarditis were not taken into 
consideration. Also patients with apparent constriction seen 
intraoperative, but lacking hemodynamic proof in the preoperative cardiac 
catheterization were excluded. 
 
6.8 FOLLOW UP 
Follow up complete in 92.5% of the patients. The mean follow up was 2.9 
± 3.8 years (range 0.1-14 years). All patients were contacted via 
telephone or questionnaire. Family members were contacted if patients 
could not be contacted or if the patient has died.  
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6.9 STATISTICS 
	
Statistical analysis was performed using IBM SPSS Statistics 20.0 (SPSS 
Inc., Chicago, IL, USA). The entire data pool was tested for normal 
distribution with the Kolmogorov-Smirnov Test. All continuous variables 
are presented as mean values ± standard deviation. The categorical are 
shown as number and percentages. Initially, the univariate stepwise 
forward logistic regression model was used to assess the relative risk 
correlated with each variable for short-term events, and the Cox 
regression model was used for long-term events. If a p value less than 
0.10 was acquired, the variable was entered into a multivariate logistic 
(for 30-day mortality) or Cox (for long-term mortality) regression model 
in order to identify independent risk factors.  
Total of 226 variables were registered and data on those points was 
collected. Out of these, univariate regression model was run on 33 
categorical variables, and on 34 continuous variables (total of 67 
variables). The following variables were taken into consideration in the 
final model of the multivariate Cox regression: age, gender, diabetes 
mellitus, arterial and pulmonary hypertension, coronary artery disease, 
symptoms duration, left ventricular ejection fraction (%), cardiac 
symptoms classified with NYHA, COPD, parameters relevant for liver 
dysfunction, ascites, edema, preoperative laboratory tests including 
creatinine, albumin, and parameters for the Child-Pugh classification, as 
well as data gained form echocardiography, and hemodynamic data as 
continuous values gained through left- and right-heart sided 
catheterization.  
 
The specificity and sensitivity of the results was surveyed using the ROC 
(receiver operating characteristic) curve (presented as graphs, for short-
term and late outcome respectively). Survival was determined using the 
Kaplan-Meier method and the significance of comparisons was obtained 
36	
	
using the logRank test. A p value of 0.05 and less was weighed 
statistically significant. 
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6.10 STATISTICAL MODEL 
	
The following variables were recorded: age, gender, diabetes, arterial 
hypertension, pulmonary artery hypertension, coronary artery disease, 
symptoms duration, symptoms classified with NYHA, ascites, and edema. 
Preoperative laboratory tests included creatinine, albumin, and 
parameters for the Child-Pugh classification. Moreover the etiology of 
pericarditis, hemodynamic results from right and left heart catheterization 
(diastolic blood pressure, wedge pressure) and operative data (need for 
cardiopulmonary bypass, additional coronary artery bypass surgery and 
concomitant valve procedures) were documented. 
All pre-, pero- and post-operative data were coded and grouped according 
to systems and any overlapping was excluded (Creatinine and GFR, LVEF 
(%) as continuous variable, and LVEF graded as ordinal etc.). Using this 
selection model, we performed a manual (forward) stepwise regression on 
the data. After reaching the aforementioned p value less than 0.10, the 
variables that were then taken into consideration to be put into the enter 
method were as follows:  
 
1) Variables taken into account for the enter method on 30 days: 
Categorical variables:     p value 
LVEF (ordinal, classified grade 1 to 3)  0.001 
NYHA Class symptoms (ordinal I-IV)   0.003 
RV dilatation (seen in echo, ordinal)   0.04 
Peripheral edema      0.1 
 
Continuous variables:     p value 
GFR         0.01 
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2) Variables taken into account for the enter method in follow up: 
Categorical variables:     p value 
COPD (GOLD I – IV)      0.002 
NYHA Class symptoms (ordinal I-IV)   0.002 
CAD ordinal, (1 – 3vessel)    0.002 
RV dilatation (seen in echo, ordinal)   0.004 
Diabetes mellitus      0.015 
Peripheral edema      0.026 
Pleural effusion      0.028 
LVEF (ordinal, classified grade 1 to 3)  0.03 
Left main coronary artery stenosis (LMCA) 0.03 
Arterial hypertension     0.04 
Lung function (ordinal)     0.055 
 
Continuous variables:     p value 
GFR (measure for renal function)   0.001 
Age         0.005 
PAPP        0.025 
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7 RESULTS 	
7.1 PREOPERATIVE CHARACTERISTICS 
Of the 97 patients, 65 were male (67%) and 32 female. The mean age 
was 60 ±12.5 years and median body mass index was 26.5±5. The main 
clinical symptom was dyspnea NYHA III-IV in 79.8%. On physical 
examination, 53 patients (54.6%) suffered peripheral edema, 59.8% had 
pleural effusion, and 34 patients (35.1%) had ascites. In 56.7% of the 
patients, symptoms increased significantly in the last 6 months. For more 
details see Table 1: 
Baseline Clinical characteristics No. or Value % 
      
Age, years 60.0 ± 12.5   
BMI 26,5 ± 5   
Male 65 67 
      
Symptom duration     
< 6 months 56 57.7 
6-12 months 17 17.5 
>12 months 25 25.8 
NYHA class     
I-II 19 20.2 
III-IV 75 79.8 
Peripheral edema 53 54.6 
Ascites 34 35.1 
Liver failure 24 24.7 
Liver cirrhosis     
Child class A 60 61.3 
Child class B 10 10.3 
Child class C 0 0 
Chest pain 27 27.8 
Pleural effusion 58 59.8 
Pericardial effusion 27 27.8 
Pericardial calcification 66 68 
Pericardial thickening * 68 95.8 
LV systolic function     
>56% 71 72.2 
31-55% 23 23.7 
<30% 3 3.1 
Right ventricular dilatation** 18 25.7 
LV diastolic dysfunction** 37 67.3 
Atrial arrhythmias 38 39.2 
 
 
Table 1:  
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Table 1 (continued): Baseline clinical characteristics 
Table 1. Baseline clinical characteristics of the cohort. * Data obtained by 
computed tomography (CT) in 77 out of the 97 patients. **The echocardiographic 
obtained data for the right ventricle dilatation and the LV diastolic dysfunction were 
measured in 70 and 55 patients, respectively. Renal insufficiency was defined as GFR<60 
ml/min/m2 longer than three months. Complete data on the renal function and GFR was 
recorded in 81 and 89 patients, respectively. BMI = body mass index, NYHA = New York 
Heart Association, LV = left ventricle, COPD = chronic obstructive pulmonary disease, 
GFR = Glomerular filtration rate by Cockcroft-Gault 
 
Cardiac cause was coronary artery disease in 38.1% and valvular disease 
in 39.2%. 
Major cardiovascular risk factors were hypertension (64.9%), diabetes 
(28.9%), smoking (33%), hyperlipidemia (39.2), pulmonary hypertension 
(44.2%) and peripheral vascular disease (10.3%). Non-cardiac risk factors 
were COPD in 32% and renal insufficiency in 53.1% (non-dialysis 
dependent in 96.9%, Table 1). 
The echocardiographic systolic left ventricular function was normal in 
72.2% (mean 58.6%±10,5 (range from 27% to 80%) and just in three 
Coronary artery disease 37 38.1 
         Left main disease 8 8.2 
         Triple-vessel disease 8 8.2 
Cardiovascular risk factors     
History of hypertension 63 64.9 
History of diabetes 28 28.9 
History of MI 6 6.2 
Smoking 32 33 
Pulmonary hypertension 43 44.3 
Cerebrovascular accident 5 5.2 
Hyperlipidemia 38 39.2 
Peripheral vascular disease 10 10.3 
      
COPD 31 32 
Renal insufficiency 22 27.2 
Dialysis dependent 3 3.1 
GFR (ml/min/1.73m2) 82.4 ± 33.9   
Diuretic usage 82 86.3 	
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patients less than 30%. The chest x-ray revealed pericardial calcifications 
in 66 patients (68%). 
Sixty-seven patients underwent left and right heart catheterization. The 
mean values of the preoperative intracardiac pressures were: left atrial 
pressure 30±10, right atrial v-wave 19±6, left ventricular end-diastolic 
pressure 21±7, right ventricular end-diastolic pressure 17±6, pulmonary 
capillary wedge pressure 20±6. The pulmonary artery pulse pressure 
index (PAPPi) were 1.7%±1 and cardiac index were 2.1±0.7. The Dip 
plateau phenomenon was evident in 67 patients (77%), Table 2: 
Table 2. Hemodynamic parameters of the patients 
Table 2. Hemodynamic parameters of the patients. The right most column (§) gives the 
number of cases in which a respective hemodynamic measurement was performed. PAPPi 
= Pulmonary artery pulse pressure index was determined in all subjects as systolic PAP - 
diastolic PAP/ CVP. PAP = pulmonary artery pressure, CVP = central venous pressure. 
  
Hemodynamic parameters No. or Value N§ 
      
Left ventricular ejection fraction (%) 61 ± 11 67 
Cardiac Index (L/min/m2) 2.1 ± 0.7 58 
Systolic blood pressure (mmHg) 116 ± 25 75 
Diastolic blood pressure (mmHg) 64 ± 12 75 
Left atrial pressure (mmHg) 30 ± 10 34 
Right atrial v-wave (mmHg) 19 ± 6 66 
Left ventricular enddiastolic pressure (mmHg) 21 ± 7 69 
Rigth  ventricular enddiastolic pressure (mmHg) 17 ± 6 61 
Pulmonary capillary wedge pressure mean (mmHg) 20 ± 6 45 
PA pulse pressure index* 1.7 ± 1.0 65 
Dip plateau phenomenon  67 (77%) 87 
 
42	
	
7.2 ETIOLOGY 
The etiology of CP is shown in Figure 9. Three main etiologic factors could 
be detected with the help of pathologic examinations. In 46.4% of the 
cases it was idiopathic etiology. CP developed after cardiac surgery in 
19.6% of the patients. Chest radiation for mediastinal neoplasm could be 
identified in 9.3% as a reason for CP. Other etiologies represented include 
autoimmune with 8.2%, tuberculous counts for 6.2%, and rheumatic 
background 4.1%. An additional six patients (6.2%) with combined 
etiologies and the latter three accounts together for the 24,7% in 
“Others”. 
Figure 9. Etiology of constrictive pericarditis 
The surgical pericardiectomy was performed through a median sternotomy 
in all patients (Table 3). The surgical technique was radical 
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pericardiectomy in 53 patients (55.2%) and a partial in 44 patients 
(44.8%). If there was need for cardiopulmonary bypass, it was usually 
established through a central cannulation of the aorta and a two-stage 
cannulation (cavoatrial) of the superior and inferior caval vein. The 
cardiopulmonary bypass time was in mean 80 (±81) minutes. In 37 
patients cardioplegic arrest was needed. In 68% the pericardiectomy were 
combined with other procedures, with CABG in 22.7% (22 patients), with 
valve surgery in 39.2 % (38 patients) and with both together in 6.2% (6 
patients). 
 
Table 3. Perioperative data 
 
  
Operative data No. or Value % 
Type of pericardiectomy     
Partial pericardiectomy 44 44.8 
Complete pericardiectomy 53 55.2 
Combined procedures     
CABG 22 22.7 
Valve surgery 38 39.2 
Aortic valve replacement 13 13.4 
Mitral valve replacement 6 6.2 
Tricuspid valve repair 29 29.9 
CABG and valve surgery 6 6.2 
Cardiopulmonary bypass 62 63.9 
Cardiopulmonary bypass time (min) 124.8 ± 68.4   
Aortic cross-clamp time (min) 74.9 ± 41.9   
Length of surgery (min) 197.0 ± 105.0   
Need for cardioplegia 37 38.1 
Type of cardioplegia     
Blood cardioplegia 21 56.8 
Cristaloid cardioplegia 16 43.2 
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7.2.1 Independent predictors for all-cause early mortality  
 
On multivariate analysis the short- and long-term outcomes were not 
influenced by the underlying etiology. Using logistic regression patients 
with reduced LVEF (35%<LVEF<55%) [P = 0.03 odds ratio (OR) 3.6 
(1.15–10.99)] and right ventricular dilatation [P = 0.04 OR 3.5 (1.04–
11.74)] were associated with a poor early survival, whereas a preserved 
LVEF > 56% was found to be protective for early mortality (OR: 0.2 
[0.084-0.714], p=0.01). 
 
7.2.2 Independent predictors for all-cause long-term mortality  
 
The long-term mortality was independently predicted again by the 
presence of coronary artery disease (HR: 6.4 [2.5-16.6], p<0.001), 
impaired renal function (HR: 1.8 [1,14-2.84], p=0.012), and COPD 
(chronic obstructive pulmonary disease) (HR: 4.2 [1.82-9.75], p=0.001).  
 
The long-term mortality due to pericardiectomy and tricuspid valve repair 
(TVR) shows that the mortality without TVR is 51.5% in comparison to 
31% with TVR; although not reaching statistical significance (p=0.07), 
this shows an important tendency. 
 
The majority of our patients who received additional TVR were operated in 
the last half of the observed period (Figure 10). The highly experienced 
personnel on all levels as well as the volume of valve surgery performed 
at our institution has pushed the additional TVR along with 
pericardiectomy to become a standard practice in our institution (Figure 
10).  
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Figure 10. Frequency and distribution of tricuspid valve repair in patients 
undergoing pericardiectomy. 
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7.3 MORTALITY 
7.3.1 All-cause mortality 
	
The cumulative survival using the Kaplan-Meier curve was 66.8 % after 
one year, and 52.6% after five-years (Figure 11). The number-at-risk are 
97 patients in total: 51 after one year, 26 after five years, and 7 patients 
after seven years. In the first 30 days (19.6% of the patients) the causes 
of death were progressive heart failure, sepsis, respiratory failure, acute 
renal failure and multiorgan failure (MOF). 
 
Figure 11. Cumulative survival of the whole cohort 
 
Survival Table
Time Status
Cumulative Proportion 
Surviving at the Time N of 
Cumulative 
Events
N of 
Remaining 
CasesEstimate Std. Error
9 1
9 2
9 3
9 4
9 5
9 6
9 7
4.999 0 . . 4 0 6
4.999 0 . . 4 0 5
4.999 0 . . 4 0 4
4.999 0 . . 4 0 3
4.999 0 . . 4 0 2
4.999 0 . . 4 0 1
4.999 0 . . 4 0 0
Means and Medians for Survival Time
Meana Median
Estimat Std. E ror
95% Confidence Interval
Estimate Std. Error
95% Confidence Interval
Low r Bound Upp r Bound Lower Bound Upper Bound
3.029 .242 2.555 3.504 . . . .
Estimation is limited to the largest survival time if it is censored.a. 
Years after surgery
543210
C
um
ul
at
iv
e 
S
ur
vi
va
l
1.0
0.8
0.6
0.4
0.2
0.0
*1 Year - 66.8%
*3 Year - 58.1%
*5 Year - 52.6%
Cumulative survival with Kaplan-Meier curve
     
  GET 
  FILE='/Users/kirilpenov/Documents/Laptop/Doktorska/CP System/SPSS Tabellen/Perikardiektomie_Auswerteset_06.11.2013.sav'. 
DATASET NAME DataSet2 WINDOW=FRONT. 
Page 4
Nr	at	risk:							48																			37																			30																				27																			23	
47	
	
7.3.2 Survival according to etiology 
	
Between the four groups (idiopathic, postoperative, post radiation and 
others) there was no significant difference (p=0.507, Log Rank (Mantel-
Cox)); however there is a tendency for a better outcome in the idiopathic 
group then in the post-radiation group.  
Figure 12 depicts the survival according to etiology. 
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7.3.3 Late survival without perioperative deaths 
 
Without perioperative deaths the late survival after one year is 82%, after 
three years 72% and after five years 65% (Figure 13). 
 
Figure 13. Kaplan-Meier survival landmark analysis for entire patient 
cohort, early death (30 days) excluded.  
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7.3.4  Isolated pericardiectomy vs. concomitant surgery 
 
Patients who received pericardiectomy alone did better than patients with 
concomitant surgery in follow-up. The latter were composed of additional 
CABG and/or additional valve surgery. Patients that received additional 
CABG surgery did worse. 	
	
Figure 14. Survival analysis of patients who received pericardiectomy 
alone vs patients with concomitant surgery, in follow-up. 
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7.3.5 Postoperative Outcomes: 
	
Postoperatively (Table 4), 19 patients (19.6%) required reoperation for 
bleeding and 27 patients (27.8%) developed a low output syndrome. 
Seven patients (7.2%) developed cardiac arrhythmia with need for 
pacemaker implantation. Postoperative dialysis was needed in 29 patients 
(29.9%) as a cause of acute renal failure. Eleven patients had infectious 
complications and developed sepsis. Reintubation due to respiratory 
failure was necessary in 26 patients (26.8%) and 14 patients (14.4%) got 
a temporary percutaneous tracheostomy. 
 
Table 4. Immediate postoperative outcome and events 
  
		
Postoperative outcome and events No. or Value % 
Thirty-day mortality 19 19.6 
Low output syndrome 27 27.8 
Re-exploration for bleeding 19 19.6 
Sepsis 11 11.3 
Postoperative pacemaker implantation 7 7.2 
Postoperative dialysis 29 29.9 
Reintubation 26 26.8 
Trachesotomy 14 14.4 
Hospital stay (days) 27 ± 20   
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7.3.6 Receiver operating characteristic (ROC) curve 
 
The optimal cutoff values of the considered variables for predicting early 
and late mortality, and the specificity and sensitivity of the gained results 
were determined using receiver operating characteristic curve analysis 
(Figure 13 and 14). The values earned through this analysis are 0,777 
(0,668-0,885) and 0,790 (0,688-0,892) concerning variables predictive 
for early and late mortality, respectively. 
Figure 15. Receiver operating characteristic curve (ROC) analysis for the 
early mortality risk factors: 
1 - Specif ic i ty
1.00.80.60.40.20.0
S
en
si
tiv
ity
1.0
0.8
0.6
0.4
0.2
0.0
ROC Curve for predictors of early outcome
p=0.01
AUC=0.777
Area Under the Curve
Test Result Variable(s):  Predicted probability
Area Std. Errora
Asymptotic 
Sig.b
Asymptotic 95% Confidence 
Interval
Lower Bound Upper Bound
.777 .055 .001 .668 .885
Under the nonparametric assumptiona. 
Null hypothesis: true area = 0.5b. 
     
  COXREG D_Follow 
  /STATUS=died(1) 
  /CONTRAST (COPD)=Indicator(1) 
  /CONTRAST (KHK)=Indicator(1) 
  /METHOD=ENTER Krea KHK COPD 
  /SAVE=XBETA 
  /PRINT=CI(95) 
  /CRITERIA=PIN(.05) POUT(.10) ITERATE(20).
Cox Regression
Page 5
52	
	
 
Figure 16. Receiver operating characteristic curve (ROC) analysis for the 
late mortality risk factors. 
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8 DISCUSSION 
 
In the present analysis, we found a reduced LVEF and a right ventricular 
dilatation to be independent predictors for early mortality. During follow-
up, concomitant CAD, chronic obstructive pulmonary disease and renal 
insufficiency were found to be independent risk factors for adverse 
outcomes. An additional TVR to the performed pericardiectomy implied a 
potential role for long-term survival. 
 
Since Richard Lower described the pulsus paradoxus in 166915 and Edward 
D. Churchill performed the first successful complete resection of the 
pericardium in 192952, followed by a remarkably successful series 
published in 1936, the constrictive pericarditis remains a silent stalker of 
the cardiac surgeons all over the world.  
 
To date, only few publications have clearly defined the risk factors of poor 
outcomes after surgery for CP. We here performed a retrospective 
analysis of an almost 100 patients undergoing surgical treatment for CP at 
a single institution in order to identify risk factors for perioperative and 
long-term mortality. Thus, this current study represents the experience of 
a single center over the last two decades and is, to the best of our 
knowledge, the most extensive study on CP patients in Europe so far. 
Nonetheless, it includes not only patients with symptoms expressing the 
constrictive pathology, but also combines patients with CAD and valvular 
pathologies. In the last 10 years, few studies worldwide presented 
consistent results concerning surgical mortality 7,8,10,53,54, ranging from 
1.2% in South Korea 8, 7% in another German centre 53 and 8.6% in 
Turkey 54. Two studies published in 2013 presented nationwide results for 
pericardiectomy: one from Tokuda et al., Japan 12, and the other from 
Gopaldas et al. 13, USA. The former one presented an operative and a 
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composite mortality or major morbidity rate of 10.0 and 15.0%, 
respectively. In our series, the 30-day all-cause mortality was 18.6%. The 
early postoperative mortality after pericardiectomy for CP still remains 
relatively high compared with other cardiac surgery mortality rates. Kang 
et al. from South Korea explained their excellent results with the fact that 
they have excluded the patients with CAD as well as those with valvular 
heart disease requiring valve surgery, peripheral vascular disease and 
post-radiation patients 8. In contrast, a majority of our patients received 
concomitant procedures under CPB. Analyzing our collective, we tried to 
explain the comparably high early mortality by the increased preoperative 
morbidity and patient demographics. Our cohort was an average 60 years 
old and, thus, the oldest reported population so far. On univariate 
analysis, we found advanced age related to early mortality. Impaired 
preoperative clinical status depicted through several physiological 
parameters, haemodynamic data and classifications concerning the 
cardiovascular, renal and endocrinological system showed statistical 
significance when tested against the early and late mortality. More than 
three-fourths of our patients were highly symptomatic (79.8% in NYHA 
IV) and 43.3% were symptomatic for at least 6 months. Along with these 
findings, a moderate reduced LVEF and a changed geometry of the RV 
appeared to be independent risk factors for early mortality. Additionally, 
we found renal insufficiency to be an independent predictor for late 
mortality. Previous studies have also shown the influence of the abnormal 
LV function and renal dysfunction 55–57 on overall survival. Patients who 
received pericardiectomy alone did better than patients with concomitant 
surgery in follow-up. The latter were composed of additional CABG and 
additional valve surgery (Figure 14). Patients that received additional 
CABG surgery did worse. It is difficult to compare the isolated and 
concomitant surgery cohorts, as the two groups were fundamentally 
different at baseline. The group of patients who required concomitant 
surgery were likely less healthy; and though their perioperative mortality 
was equivalent, the long-term survival diverged. Additionally, operative 
details were different between the two groups including longer CPB and 
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cross-clamp times. Similar findings concerning the use of CPB were seen 
in the study of George et al. 7. We found only few studies reporting 
combined pericardiectomy and concomitant surgical procedures, among 
them the nationwide studies from Japan and USA 7,12,13,50,53. There were 
some case reports presenting experience in simultaneous combined 
surgery for CP and other congenital or acquired heart diseases 58–60. 
Furthermore, our collective is composed of almost 20% patients after 
previous cardiac surgery and 10% patients with history of mediastinal 
radiation. These findings are in line with more recent studies from the 
world. 30% and 17% of patients from the Baltimore cohort had previous 
cardiac surgery and a history of mediastinal radiation, respectively 7. In 
the cohort from the Mayo Clinic, this was 37% and 9%, respectively 55. In 
another setting, the surgeons asked if the pericardiectomy for post-
irradiation CP was not futile 61,62. Subsequently, looking at the late 
survival (Figure 13) in our combined collective, we can conclude that the 
pericardiectomy is justified and effective for symptom relief for patients 
with chronic CP. 
 
CAD is the number one cause of death among the general population. 
Combined with CP in highly symptomatic patients with a multi-morbidity 
load, it represents a deleterious risk factor, as shown in our study. There 
is a lack of proof concerning the effects of the combination CAD and CP—a 
fact clearly pictured for the general population through the study by 
DuGoff et al. 63. In addition, chronic diseases cumulatively worsen the 
survival, a combination typically present in CP patients, which explains the 
additional risk this study population is put under. COPD could be 
deleterious in terms of weaning from the ventilator 64 as well as in 
haemodynamic terms 4 also shown in our study. COPD represented an 
additional independent risk factor for the late adverse outcome in our 
study. This fact is supported by many studies conveyed in the general 
population 65 as well as for CP 13. The preoperative kidney function is 
crucial for the early and late mortality and morbidity among different 
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patient collectives as well as in CP patients 55,66. In our collective, the 
renal insufficiency represented a risk factor for late mortality, a fact also 
found in the study by Bertog et al. 55  
 
Concerning the tricuspid valve pathology, in the analysis by the Mayo 
Clinic in Rochester from 2008, the authors 50 reported that the presence of 
significant tricuspid regurgitation (TR) was associated with a reduced early 
and late survival. They concluded that since intervention on the valve had 
little impact on patient survival, the TR indicates a more advanced 
underlying disease. Our experience showed somewhat similar results and, 
hence, throws a better light on the TVR in a pericardiectomy setting. In 
the cohort, there were 29 patients with mild TR, 14 with moderate TR and 
9 with severe TR. The indication for TV repair, however, was not only the 
grade of preoperative TR, but also concern for postoperative RV dilatation 
with subsequent new onset TR. This was based on the experience at our 
centre with several CP surgeons. Unfortunately, the small number of 
patients and the heterogeneity of patient characteristics prevent an in-
depth analysis of this. Interestingly, TV repair seems to be protective, and 
this might serve as a good argument to recommend TV repair liberally in 
CP patients. Almost all patients received a flexible annuloplasty ring rather 
than a DeVega or Kay annuloplasty. The findings presented disclose the 
importance of the timing of the operation. CP is a rare but serious disease 
53. The low incidence does not allow randomization; hence, we are limited 
in providing the best evidence-based pre-, peri- and post-operative care 
to these patients. Since CP is an uncommon finding and a disease with 
relevant regional diversity of the aetiology, we see an importance in 
generating an European-wide report similar to that of the Japanese 
nationwide study 12 and the US-American one 13. This could bring up a 
clearer view on the preoperative states that lead to better outcome, an 
optimized patient selection and timing of surgery as well as utilizing the 
medical therapy. 
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8.1.1 Personal thoughts and future directions 
	
Even though constrictive pericarditis in not such a rare diseae, yet in the 
world’s best medical centers it has a relative high mortality compared to 
other operations in the cardiac surgery. The short-term survival is in the 
range of 2% to 15%, while in our case with the combined surgery, almost 
19%. The average 5-7 years survival ranges from 88% in idiopathic 
constrictive pericarditis to 27% in post-radiation constriction55. Compared 
to the long-term survival of the ICM, DCM, and even with cancer, it is still 
high enough to draw our attention to it. Maybe one reason why this 
disease is not in the scope of researchers is that it is yet too rare and 
difficult to diagnose in order to be able to plan, assign and randomize 
patients for a prospective study, and that it is difficult to establish an 
appropriate animal model for experiments. There are few basic science 
laboratories throughout the world that are interested in the physiology 
and pathology of the pericardium, but no concrete model has been 
established so far to examine the molecular and genetic basis of the 
changing pericardium.  
 
As our postoperative data show - and also from clinical experience with 
patients suffering from chronic CP who underwent surgical 
pericardiectomy - the postoperative course is often complicated by a vast 
myriad of symptoms that are rare after isolated valve or coronary surgery. 
Just to mention that in wide variety of cases, a so called vasoplegic 
syndrome is present; then the inevitable SIRS reaction even in patients 
who were not operated on cardiopulmonary bypass, postoperative 
bleeding, signs and symptoms of right and left heart failure, new onset 
arrhythmia, sepsis-associated hemodynamic changes. As a consequence 
of many of these - some alone and other in a combination – it results in a 
prolonged postoperative ventilation time, acute renal failure and need for 
intermittent dialysis, prolonged use of antibiotics and consecutively 
development of multi-resistant bacteria etc. 
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Two hypotheses can be discussed for the almost inevitably present 
postoperative vasoplegic syndrome, which in the postoperative course 
represents a serious problem.  The first one is a more mechanistic one 
and can be explained by the law of physics. The second is connected to 
the endocrinological pathways. 
 
1. The peripheral veins are chronically dilated due to fluid retention; 
perhaps their smooth muscle layer requires a longer time to adapt 
to the new condition in order to build up the tonus. Adequate 
venous tonus will reduce the need for volume substitution after 
surgery.  
2. The endocrinologic role of the right heart, secretion of ANP and BNP, 
as well as the cardio-renal axis.  
 
In addition to what was said so far, we have to bear in mind that we are 
facing a more complex problem than what appears on the surface. The 
constricted and “untrained” myocardium atrophies over time; although we 
see no coronary artery disease, the myocardial pump strength is 
diminished. In post-radiation constriction, not only the pericardium is 
stiffened, but also the myocardium is more fibrotic than usual. The 
localized epicardial lesions caused during pericardiectomy may exert organ 
specific effects, but also may contribute to a systemic inflammatory 
reaction. For most of these concerns, an extended preoperative diagnostic 
including MRT67 for every patient may definitely help in distinguishing the 
constriction from restriction and also may identify myocardial atrophy, and 
also may localize motion restriction possibly due to tight adhesions 
between the pericardium and the epicardium.  
 
The seriousness of constrictive pericarditis and the surgical 
pericardiectomy remain an open field for clinical and basic science 
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research. Many teams worldwide are expanding their field of interest in in-
depth basic and translational research on constrictive pericarditis67–69; 
there is already an established animal model70; few candidate genes are 
identified in families that are under greater burden of developing 
constriction in their lives22,23 and maybe there is a way using personalized 
medicine to help them prevent progression of disease71; old assumptions 
are being tested in prospective randomized trials44,72,73… Constrictive 
pericarditis is rare but not forgotten and the medical community is on the 
way to discover novel targets, modes and therapeutics to cure the 
disease. 
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9 LIMITATIONS 
 
Our study comprises the most extensive patient collective in Europe to 
date. Nonetheless, our study population is heterogeneous, with more than 
half of the patients receiving concomitant procedure as CABG or valve 
surgery. Furthermore, the low incidence of CP does not allow for 
randomization. The study was retrospective and has by nature fight 
against these limitations; e.g. we used different surgical strategies. 
Moreover, invasive haemodynamic measurements were not assessed in all 
patients. Thus, we could not include all univariate significant variables 
with many missing values into the multiple models. 
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10 CONCLUSION 
From the presented above we can a draw few important notes: 
 
First, surgery for constrictive pericarditis is still associated with significant 
early and long-term mortality, but has to be weighed against the 
otherwise poor natural prognosis of the disease. The natural course of the 
disease as it progresses affects multiple systems; in its late stages it is 
often hard to return the affected organs to normal. Surgical removal of 
the diseased pericardium is the only causative treatment so far. After all 
conservative measures and modalities were exhausted, the only causal 
treatment is surgical pericardiectomy.  
 
Further, we found that moderate reduced left ventricular ejection fraction 
(LVEF) and dilated right ventricle (RV) increase early mortality. The LVEF 
is often overestimated due to the relative intravascular fluid depletion, 
and the limited motion of the LV due to the constriction. The RV geometry 
is very important in its normal function. 
 
And finally, pre-existing coronary artery disease as well as chronic 
obstructive pulmonary disease (COPD) and an impaired preoperative renal 
function independently predict overall survival.  
 
An additional TVR might be protective and should be indicated liberally. 
Most importantly, the optimal timing for surgery on CP remains crucial to 
prevent secondary morbidities with a worse natural and operative 
prognosis.  
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11 SUMMARY 
	
Constrictive pericarditis is a relatively rare disease, and its only curative 
treatment to date is surgical pericardiectomy aiming removal of the 
diseased pericardium. Although cardiac surgery in the past few decades is 
marked by reduced operative mortality and morbidity and is becoming 
more and more minimally invasive, the world’s experience with surgical 
pericardiectomy is still comparably worse. This was the reason, among 
others, to perform this work and to recognize risk factors that determine 
early and long-term outcomes. Further we wanted to describe the patients 
affected by constrictive pericarditis in order to recognize risk patterns for 
future improvements in approaching the disease from cardiologic and 
surgical point of view. We analyzed the prospective collected data on all 
patients surgically treated in our clinic between 1995 and 2012. The 
diagnosis was met either on cardiac catheterization and other appropriate 
imaging or during surgery. 
 
In this retrospective, descriptive-explorative cohort-study, we included 97 
patients with a mean age 60.0±12.5 years, ranging from 16.8 to 79.7 
years. Nearly two thirds of all patients were male (65%). All patients were 
contacted via post with a follow up questionnaire (Attachment 2), and we 
received answers of 90 patients (92.8%). Median follow-up was 1.2 
(±4.0) years, and the mean was 3.1 years. The underlying etiology of the 
disease was idiopathic in almost half of the cases, followed by pericardial 
constriction after previous surgery 19.6%, after previous mediastinal 
radiation in 9.3%, tuberculosis in 6.2% of the cases, rheumatic disease in 
4.1%, autoimmune disease in 8.2% and miscellaneous in 24.7% of 
patients. Few patients had combined pathology (6.2%). More than half of 
all the patients underwent radical pericardiectomy (55.2%); the 
remaining, partial. Univariate analysis did not reveal any differences in the 
survival between the two surgical options.  
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For isolated pericardiectomy, the use of the cardiopulmonary bypass 
(CPB) is not always necessary. In our case, we had 43 patients with 
isolated pericardiectomy (40 patients without HLM, 30 patients on HLM 
without cross-clamp i.e. beating heart), and 54 patients (55.7%) with 
concomitant cardiac surgery. In general, 62 patients were placed on CPB; 
in 33 out of these patients cardioplegic arrest was performed. The total 
procedure time was 197.0 ± 105.0 minutes, the CPB time was 124.8 ± 
68.4 minutes, and the cross clamp time when applied was 74.9 ± 41.9 
minutes. Patients with concomitant procedures did worse compared to 
isolated pericardiectomy, especially patients with an additional CABG. On 
the other hand, patients that received tricuspid valve repair (TVR) trended 
towards improved long-term survival. Overall 30-day, 1-year and 5-year 
survival rates were 66.8%, 58.1% and 52.6%, respectively.  
Multivariate analysis of 77 patient-specific and surgical variables revealed 
patients with reduced left-ventricular ejection fraction and preoperative 
right-ventricular dilatation to be under significant risk of early mortality 
(OR 3.6 and 3.5, respectively). Long-term mortality was independently 
affected by the presence of coronary artery disease, chronic obstructive 
pulmonary disease, and preoperative impaired renal function (OR 6.4, 4.1 
and 1.8 respectively). 
In conclusion, surgery for constrictive pericarditis is still associated with 
high risk, mostly due to the poor preoperative status of the patients. Our 
experience supported partial over radical pericardiectomy, whenever 
justified, and we suggest TVR should be indicated liberally. Reduced LV-EF 
and distorted RV geometry were associated with high early mortality. 
CAD, COPD, and renal insufficiency negatively affected the long-term 
survival. Thus, an optimal timing for surgery on CP remains crucial to 
avoid secondary morbidity with an even worse natural prognosis.  
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13 ATTACHMENTS	
 
13.1 DIAGNOSTIC	APPROACH	IN	CONSTRICTIVE	PERICARDITIS	
 
Taken from the Guidelines on the Diagnosis and Management of 
Pericardial Diseases - Executive Summary, from The Task Force on the 
Diagnosis and Management of Pericardial Diseases of the European 
Society of Cardiology, EHJ 2004 
 
* Task Force members, Bernhard Maisch, Chairperson* (Germany), Petar 
M. Seferovic (Serbia and Montenegro), Arsen D. Ristic (Serbia and 
Montenegro), Raimund Erbel (Germany), Reiner Rienmueller (Austria), 
Yehuda Adler (Israel), Witold Z. Tomkowski (Poland), Gaetano Thiene 
(Italy), Magdi H. Yacoub (UK); ESC Guidelines: Guidelines on the 
Diagnosis and Management of Pericardial Diseases, Executive Summary. 
The Task Force on the Diagnosis and Management of Pericardial Diseases 
of the European Society of Cardiology. European Heart Journal (2004) 25, 
587–610, Page 596. Published by Elsevier Ltd on the behalf of The 
European Society of Cardiology. Material reprinted by permission of 
Oxford University Press, and The European Society of Cardiology. 
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13.2 FOLLOW-UP	QUESTIONNAIRE		
 
  
Leipzig, 01.12.2011 
 
Sehr geehrte/r __________ 
 
Sie wurden am <OP-Datum> im Herzzentrum Leipzig operiert. Die 
erfolgte Perikardektomie bei chronischer Perikarditis konstriktiva ist eine 
verhältnismäßig seltene und komplizierte Operation. Wir möchten nun im 
Rahmen einer am Herzzentrum Leipzig durchgeführten Nachuntersuchung 
feststellen, wie es Ihnen nach der Entlassung aus dem Krankenhaus 
genau ergangen ist.  
 
Hierzu bitten wir Sie persönlich um Ihre Mithilfe! 
 
Bitte füllen Sie die beiliegenden Fragebögen soweit es Ihnen möglich ist 
aus und senden Sie diese in dem bereits ausreichend frankierten 
Rückumschlag an uns zurück. 
Da die Fragebögen getrennt voneinander analysiert werden, kommt es 
gelegentlich zu ähnlichen Fragestellungen. Wir bitten Sie trotzdem, diese 
gewissenhaft zu beantworten. 
Selbstverständlich werden alle von Ihnen gemachten Angaben, wie auch 
Ihre persönlichen Daten, streng vertraulich behandelt und ausgewertet. 
Hinweise zum Ausfüllen des Fragebogens liegen bei. 
 
Bei offenen Fragen ziehen Sie bitte Ihren Hausarzt oder Kardiologen zu 
Rate und fügen Sie, wenn möglich, nach Absprache mit Ihrem Arzt 
wesentliche vorliegende Krankenhausbriefe, EKG- und Echo-Befunde und 
sowie ggf. Schrittmacher-Abfragebefunde bei. 
 
Wir würden uns sehr freuen, wenn Sie die Fragebögen möglichst bald an 
uns zurück senden würden. 
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Liebe Angehörige, 
sollte Ihr Angehöriger zwischenzeitlich verstorben sein, möchten wir unser 
Bedauern darüber ausdrücken. Entschuldigen Sie bitte, dass uns dies im 
Vorfeld nicht immer bekannt sein kann. In diesem Fall würden wir Sie 
gerne bitten, den Fragebogen nach Ihrem besten Wissen für Ihren 
Angehörigen auszufüllen und mit einem kurzen Vermerk über das 
Todesdatum ebenfalls in dem beiliegendem Umschlag zurückzusenden. 
 
Mit freundlichen Grüßen und herzlichem Dank für Ihre Bemühungen, 
 
 
PD Dr. med. A. Rastan 
Oberarzt der Klinik für Herzchirurgie 
 
Hinweise zum Ausfüllen des Fragebogens: 
 
1. Die von Ihnen gemachten Angaben unterliegen der ärztlichen 
Schweigepflicht und werden von uns streng vertraulich behandelt sowie 
nur in anonymisierter Form ausgewertet. 
 
2. Bitte beantworten Sie alle Fragen, auch wenn Ihnen manche Fragen sehr 
ähnlich und deshalb überflüssig vorkommen. 
 
3. Bitte beantworten Sie die Fragen möglichst selbstständig oder besprechen 
Sie diese mit Ihrem Hausarzt. Es gibt keine richtigen, falschen oder gar 
dumme Antworten.  
 
4. Sollten Sie die Fragen nicht verstehen oder sonstige Bemerkungen machen 
wollen, benutzen Sie bitte den Freiraum für Notizen. 
 
Bei Rückfragen stehen wir Ihnen natürlich selbstverständlich unter der 
Telefonnummer 0341/865-251007 oder -252508 zur Verfügung. 
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Nachsorge-Fragebogen	für	Patienten	mit	einer	Perikardektomie	bei	einer	chronischen	Perikarditis	
konstriktiva	(Panzerherz).	
 
 
Name, Vorname:     geb.:    
 
  
 
Die folgenden Fragen beziehen sich zunächst auf Einzelheiten Ihres 
Gesundheitszustandes VOR der Operation: 
1. Wann wurde bei Ihnen die Perikarditis konstriktiva (Panzerherz) erstmals festgestellt 
(Monat/Jahr)? 
         /              unbekannt 
 
2. Welche Beschwerden hatten Sie vor der Operation? 
Litten Sie unter Brustschmerzen? 
 
 
 
Litten Sie unter Luftnot? 
 
 
 
Haben Sie gegen Abend Wasser in den Beinen (Unterschenkelödeme)? 
    ja        nein 
Wie oft müssen Sie nachts auf die Toilette? 
    1x        > 2x 
 
Werden Sie nachts wegen Luftnotanfällen wach? 
    ja        nein 
    nein   
    ja, bei schwerer körperlichen Belastung	
												     ja, bei leichten körperlichen Tätigkeiten im alltäglichen Leben   
    nein   
    ja, bei schwerer körperlichen Belastung	
											     ja, bei leichten körperlichen Tätigkeiten im alltäglichen Leben   
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3. Nahmen Sie vor der Operation blutverdünnende Medikamente ein? 
    nein 
    ja, Herz-ASS, Aspirin 
    ja, Falithrom, Marcumar 
    ja, Plavix, Tyklid 
    ja, Heparin 
 
 
Die folgenden Fragen beziehen sich auf Einzelheiten Ihres AKTUELLEN 
Gesundheitszustandes. Wir bitten Sie, diese evtl. gemeinsam mit Ihrem Hausarzt 
zu beantworten. Bitte kreuzen Sie die Kästchen an. 
4. Bitte tragen Sie hier Ihre aktuellen Medikamente ein:  
______________________________         __________________________________  
______________________________        __________________________________ 
______________________________         __________________________________  
______________________________        __________________________________ 
 
5. Traten seit der Entlassung nach der Operation bei Ihnen Komplikationen auf? 
a) Lähmungen/Gefühlsstörungen □  nein □  ja  Datum:  
Wenn ja, welche ?        
b) Schlaganfall   □  nein □  ja  Datum: 
     Folgen des Schlaganfalls:  
c) Hirnblutung  □  nein □  ja  Datum:  
  d) Andere Blutungen mit einem der folgenden Kriterien 
    □ stationär behandlungspflichtig  
    □ Bluttransfusion 
    □ OP-pflichtig 
    □ innere Blutung,     wenn ja, welche ? 
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  e) Gefäßverschluss an Arm/Bein   □ nein □ ja  Datum: 
  f) Herzinfarkt     □ nein □ ja  Datum:  g) 
andere Komplikationen    □ nein □ ja  Datum :   
   Wenn ja, welche? 
 
6. Im Falle einer Hirnschädigung, wie stark behindert Sie Ihre Hirnschädigung?  
□   keine Einschränkung im Alltag 
□   leichte Einschränkung bei bestimmten Tätigkeiten, aber keine Hilfe notwendig 
□   mäßige Einschränkung, Hilfestellung  notwendig, aber Gehen ohne Hilfe 
□   mittlere Einschränkung: Hilfestellung beim Gehen und bei der täglichen Pflege 
□   schwere Einschränkung: bettlägerig, Inkontinenz, ständige Pflegebedürftigkeit  
 
7. Waren Sie seit Ihrer Operation erneut im Krankenhaus? 
   □ nein  
   □ ja  Wann:  ______________________________  
     Wie lange: ______________________________ 
     Warum: ______________________________ 
 
8. Letzter Besuch beim Hausarzt/Kardiologen: ________________________ 
Wurde dabei ein EKG geschrieben?  □ nein □ ja 
Befund:           
     □ Sinusrhythmus □ Vorhofflimmern 
 
9. Welche aktuellen Beschwerden haben Sie? 
Leiden Sie aktuell unter Brustschmerz? 
 
 
  nein    
  ja, bei schwerer körperlichen Belastung	
												  ja, bei leichten körperlichen Tätigkeiten im alltäglichen Leben   
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Leiden Sie aktuell unter Luftnot? 
 
 
 
 
Müssen Sie im Moment beim Treppensteigen nach einer bestimmten Anzahl von 
Stufen/Stockwerken auf Grund von Atemnot oder Brustschmerz eine Pause einlegen? 
 
 
 
Haben Sie gegen Abend Wasser in den Beinen (Unterschenkelödeme)? 
    ja        nein 
Wie oft müssen Sie nachts auf die Toilette? 
    1x        > 2x 
 
Werden Sie nachts wegen Luftnotanfällen wach? 
    ja        nein 
 
Leiden Sie unter Herzstolpern  □ nein □ ja 
 
Haben Sie nach der Operation eine Änderung ihres Gewichtes? 
       ja      abgenommen   _____ wieviel kg? 
         zugenommen  _____ wieviel kg? 
       nein 
Haben Sie nach der Operation eine Bauchumfangszunahme (in form von Wasser im Bauch 
= Ascites)? 
    ja        nein 
 
  nein   
              ja                           Anzahl der Stufen:  	 	 							
  nein    
  ja, bei schwerer körperlichen Belastung	
												  ja, bei leichten körperlichen Tätigkeiten im alltäglichen Leben   
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10. Wenn möglich, bitten wir um Mitgabe eines weitgehend aktuellen Laborbefundes 
(Nierenretentionsparameter und Leberwerte z.B. Bilirubin, ALAT, ASAT, Gesamteiweiß, 
Quick/INR) 
 
 
Für den Fall, dass Ihre Angehörige/Angehöriger zwischenzeitlich verstorben ist, würde wir 
Sie bitten, nachfolgend das Sterbedatum und soweit Ihnen bekannt, die Todesursache 
einzutragen: 
Datum:  ____________      Todesursache: ______________________ 
 
Nochmals vielen Dank für die Zeit und Ihre Bemühungen. 
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